Innovative innovation Funding

Or: How we accidentally discovered that fixing funding timing creates the best competitor intelligence system ever

The Innovation Funding Timing Disaster (You Know This Story)

Picture this: A brilliant researcher discovers a breakthrough therapy. It's genuinely revolutionary - peer-reviewed, reproducible, the works. But they can't get funding because it's "too early." So they bootstrap with savings, max out credit cards, and finally build a working prototype.

Now they need serious money. Big money. But here's the catch - they've already burned through savings and given away 70% of their company just to survive the "too early" phase. They're exhausted, demoralized, and barely own their own discovery.

Sound familiar? It's the same story whether it's cancer therapy, revolutionary engines, quantum computing, or literally any innovation that matters. And something very close to home

Dr. Manel Torres and Professor Paul Luckham at Imperial College London created revolutionary spray-on fabric technology that generated $26.3 million in media value from a single viral moment, yet failed to achieve commercial success after 25 years of development. You can read the whole sorry tale here: https://ethcrl.ghost.io/spray-on-dress/

The timing is always wrong: Too early for serious money, too broke to wait, too diluted to stay motivated.

The Broke Ass Minimal Solution

What if we just... fixed the timing?

The idea: Progressive equity pricing tied to actual risk reduction, enforced by embarrassingly simple blockchain tech.

• Stage 1: 5% max equity for technical validation ("Yes, the science works")
• Stage 2: 8% max additional for clinical/market validation ("Yes, people want this")
• Stage 3: 15% max additional for scale validation ("Yes, we can build a business")

The technology: ENS names pointing to IPFS storage. ENS provides global, uncensorable naming that no single entity controls. IPFS provides tamper-proof, distributed storage where any attempt to alter records becomes immediately visible through hash changes. This combination creates verifiable milestone tracking that can't be captured, corrupted, or controlled by any organization.

acmecorp.pharmaceutical.funding.standard.eth → IPFS containing:
├── Current Stage: 2 (Market Validation)
├── Equity Issued: 13% total (5% + 8%)
├── Next Milestone: "Clinical trial results"
├── Evidence: [Cryptographic proof of technical success]
└── Founder Ownership: 87% (and motivated!)

Why ENS + IPFS specifically?

ENS (Ethereum Name Service): Global, decentralized naming that no government, corporation, or organization can control or censor. Unlike DNS (controlled by ICANN/governments) or corporate databases (controlled by companies), ENS names can't be seized, redirected, or manipulated by any single entity.

IPFS (InterPlanetary File System): Content-addressed, tamper-proof storage that's distributed across thousands of nodes globally. If someone tries to change the milestone evidence, the hash changes and the fraud becomes immediately visible. Unlike cloud storage or corporate servers, no single entity can alter or delete the records.

Why not other tech?: We need something that can't be captured by any single organization, works globally without permission, is tamper-proof, and is simple enough not to become the complexity problem itself. Traditional databases can be altered. Corporate platforms can be shut down. Only blockchain infrastructure provides the neutrality and permanence needed.

The Cheeky Bit: Everyone Gets Their Own Brand

Instead of one monolithic "Innovation Standard," every prestigious pairing gets their own:

• bigtech.university.funding.standard.eth
• pharma.research-institute.funding.standard.eth
• vc.accelerator.funding.standard.eth
• corporate.lab.funding.standard.eth

The beautiful part: They're not competing - they're mutually reinforcing! When one university's spin-out needs growth capital: "Try this VC, they use compatible methodology." When a startup is too early for one fund: "This accelerator has a pre-seed standard that transfers perfectly."

Everyone gets their own prestige while building one ecosystem.

The Competitor Intelligence Goldmine

Here's where it gets really cheeky: transparency becomes the competitive advantage.

When major organizations adopt innovation standards, they're not revealing secrets - they're establishing themselves as the entities that attract the best partnerships. And yes, you can see their innovation pipeline milestones, but that's actually the point.

The counter-intuitive insight: In innovation, copying is slow and creation is fast. By the time competitors figure out what you're doing, you've already moved three steps ahead. Meanwhile, you get to see everyone else's milestone achievements in real-time.

Example: One company's breakthrough methods become visible infrastructure that other researchers can build on. Another organization's delivery innovations become resources for different industries. Cross-fertilization makes everyone stronger while creating competitive moats through speed and partnership quality.

The Biblical Economics (Stay With Me Here)

This isn't just about money - it's about restoring proper order to how innovation should work.

Current system: Force brilliant researchers to humiliate themselves by pretending to be entrepreneurs, punish intellectual honesty ("I need to prove the science first"), extract maximum equity during desperation.

Innovation Standard: Reward good stewardship and honest assessment of what's proven vs. what needs work. Intellectual humility becomes profitable instead of punished.

The result: Innovators keep meaningful ownership, stay motivated through scale-up, and their breakthroughs actually reach market instead of dying in funding hell.

Why This Could Actually Happen

For universities: Protect researchers while enabling systematic commercialization For VCs: First-mover advantage in founder-friendly funding, better deal flow For corporates: Co-brand with prestigious institutions, systematic innovation pipeline For researchers: Keep ownership, maintain dignity, focus on actual innovation

The network effect: Each new partnership makes all existing partnerships more valuable through cross-referrals and methodology sharing.

The Immediate Opportunity

Organizations that pioneer this approach get first-mover advantage in founder-friendly innovation funding. From there, it's about scaling the methodology across elite institutions and funds.

The long game: Transform from "another VC" or "another university" to "the infrastructure that powers how innovation funding works."

The Cheeky Conclusion

We set out to fix innovation funding timing and accidentally discovered that the best competitor intelligence system is just... being really good at helping innovations succeed.

When your methodology enables breakthrough therapies, quantum computers, and revolutionary engines to actually reach market instead of dying in funding gaps, everyone wants to work with you.

The ultimate cheeky bit: Doing good for others becomes the most profitable strategy. Not through guilt or mandate, but through economic design that makes virtue profitable and vice unsustainable.

Sometimes the most revolutionary thing you can do is just... make the simple stuff work properly.

Want to help build this? Whether you're from academia, VC, corporate innovation, or just tired of watching brilliant innovations die for stupid reasons, there's a place for your expertise in creating standards that actually work.

Because the future of innovation funding isn't about better technology - it's about better coordination. And better coordination starts with broke ass minimal infrastructure that gets out of the way and lets brilliant people do brilliant work.